Subbiah, V., McGregor, B. A., Dumbrava, E. E., Italiano, A., Garralda, E., Shreenivas, A. V., Shitara, K., Zhang, A. Y., Theron, M., Hiemeyer, F., Mussi, C. E., Daniele, G. (2025). panSOHO: Phase II trial of BAY 2927088 in patients with unresectable or metastatic solid tumors other than NSCLC with HER2 -activating mutations.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps3185